Free Trial
NASDAQ:GDRX

GoodRx Q3 2025 Earnings Report

GoodRx logo
$4.27 -0.37 (-7.97%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$4.18 -0.09 (-2.22%)
As of 10/10/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GoodRx EPS Results

Actual EPS
N/A
Consensus EPS
$0.09
Beat/Miss
N/A
One Year Ago EPS
N/A

GoodRx Revenue Results

Actual Revenue
N/A
Expected Revenue
$195.17 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GoodRx Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, November 5, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

GoodRx Earnings Headlines

GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.tc pixel
GoodRx spikes after report on plans to join TrumpRx
See More GoodRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email.

About GoodRx

GoodRx (NASDAQ:GDRX) (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs. Users can connect with licensed healthcare professionals online for diagnostics and treatment, with the option to have prescriptions delivered to their home or sent to a local pharmacy. GoodRx also markets GoodRx Gold, a membership program that further reduces out-of­-pocket costs for prescription drugs, as well as GoodRx Shop, an e-commerce marketplace for health and wellness products.

Founded in 2011, GoodRx is headquartered in Santa Monica, California, and focuses its operations on the U.S. market. The company went public in 2020, listing its shares on the Nasdaq exchange. Over the years, GoodRx has expanded its partnerships with pharmacy benefit managers, major retail pharmacy chains, and pharmaceutical manufacturers to broaden its discount offerings and enhance access to affordable medications for millions of Americans.

GoodRx’s leadership team includes co-founder Doug Hirsch, who serves as Executive Chairman, and Trevor Bezdek, who holds the role of Chief Executive Officer. Under their guidance, the company has pursued strategic acquisitions and product innovations aimed at simplifying healthcare navigation, improving price transparency and expanding virtual care services. GoodRx continues to evolve its platform to address the changing needs of consumers, healthcare providers and pharmacy partners nationwide.

View GoodRx Profile

More Earnings Resources from MarketBeat